CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 1 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $8,347,000 | -16.6% | 10,434,000 | 0.0% | 0.02% | -34.5% |
Q2 2018 | $10,006,000 | +1631.1% | 10,434,000 | +6421.2% | 0.03% | +1350.0% |
Q4 2016 | $578,000 | -14.9% | 160,000 | +45.1% | 0.00% | 0.0% |
Q3 2016 | $679,000 | +52.9% | 110,250 | -8.1% | 0.00% | +100.0% |
Q2 2016 | $444,000 | -26.6% | 120,000 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $605,000 | -4.6% | 120,000 | +50.0% | 0.00% | 0.0% |
Q4 2015 | $634,000 | +56.5% | 80,000 | +60.0% | 0.00% | +100.0% |
Q3 2015 | $405,000 | -33.7% | 50,000 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $611,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,857,667 | $10,573,000 | 10.68% |
Clarus Ventures, LLC | 2,752,488 | $10,184,000 | 8.91% |
Rhenman & Partners Asset Management AB | 345,100 | $1,277,000 | 0.23% |
SPHERA FUNDS MANAGEMENT LTD. | 203,243 | $752,000 | 0.20% |
Camber Capital Management LP | 1,000,000 | $3,700,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $2,381,000 | 0.09% |
FT Options LLC | 15,059 | $56,000 | 0.05% |
FRED ALGER MANAGEMENT, LLC | 86,782 | $321,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,700 | $102,000 | 0.00% |
FIRST NEW YORK SECURITIES LLC /NY | 750 | $2,775,000 | 0.00% |